Home » Advocacy » Federal Government Relations

Federal Government Relations

The 340B Drug Discount Program
February 12, 2013

Congress created the 340B program in 1992 to help uninsured indigent patients gain better...

BIO's 2013 Legislative Priorities
January 21, 2013

Brent Del Monte, BIO’s Vice President of Federal Government Relations, discusses the...

Biofuels Power the Great Green Fleet
July 18, 2012

LtGen John "Glad" Castellaw explains how the U.S. military will validate the use of...

Therapeutic Discovery Project Defending America's Competitiveness in Biotechnology
April 9, 2012

Capital formation challenges in the industry have forced many biotech companies to halt...

More Articles →

Letters, Testimony & Comments

Pandemic and All-Hazards Preparedness Reauthorization Act
December 18 2012
BIO President and CEO Jim Greenwood wrote a letter in support of H.R. 6672, the Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA) of 2012, sponsored and championed by Chairman Mike Rogers (R-MI).
The Renewable Fuels Standard: A Successful Federal Policy that Must Be Defended
October 18 2012
A keynote Address by James C. Greenwood, President & CEO of BIO, to RETECH 2012 in Washington, DC on October 18, 2012.
IP Attache Program: BIO's Congressional Hearing Comments
June 28 2012
The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to enhance IP protection abroad for U.S. interests.
Oppose Costly & Confusing Labeling Amendment to the Agriculture Reform, Food and Jobs Act of 2012
June 21 2012
Senators Sanders and Boxer have introduced an amendment that will result in costly and extreme food labeling requirements.
The Farm Bill: BIO Opposes the Sanders-Boxer Amendment
June 21 2012
BIO, which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers, and related organizations around the world, strongly opposes the Sanders-Boxer Amendment (#2310) to the Farm Bill.
More Letters, Testimony & Comments →

Press Releases

BIO Praises House of Representatives for Passing H.R. 701
May 16 2013
H.R. 701 sets a deadline to complete rule-making on Regulation A reforms.
BIO applauds Rep. David Schweikert for Introducing Spread Pricing Liquidity Act
May 15 2013
H.R. 1952 will stimulate trading for small public companies.
BIO Applauds Reps. Hurt and Meeks for Introducing H.R. 1564 to Avoid Burdensome Regulations
April 16 2013
Bill would allow emerging biotech companies to maintain a working relationship with their independent auditor.
BIO Praises the U.S. House of Representatives for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act
March 5 2013
On March 4, 2013, the U.S. House of Representatives passed PAHPRA by a vote of 370-28.
BIO Praises U.S. Senate for Passing the Pandemic and All-Hazards Preparedness Reauthorization Act
February 28 2013
BIO lauds the Senate for passing H.R. 307, the Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), yesterday by a unanimous vote.
More Press Releases →